Alzheimer's Disease Long-Term Follow-Up Study (ALF Study).

Trial Profile

Alzheimer's Disease Long-Term Follow-Up Study (ALF Study).

Completed
Phase of Trial: Phase IV

Latest Information Update: 03 May 2012

At a glance

  • Drugs Donepezil (Primary)
  • Indications Alzheimer's disease
  • Focus Therapeutic Use
  • Acronyms ALF
  • Sponsors Eisai Korea
  • Most Recent Events

    • 03 May 2012 Actual patient number 114 added as reported by ClinicalTrials.gov.
    • 03 May 2012 Actual end date (December 2006) added as reported by ClinicalTrials.gov.
    • 03 May 2012 Additional lead trial centre and investigator added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top